| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/24/2007 | US7208490 Having useful antibacterial activity against a wide range of human and veterinary pathogens; for therapy of microbial infections in mammals |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208477 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 04/24/2007 | US7208471 Glycopeptide phosphonate derivatives |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208165 Human cytomegalovirus DNA sequences |
| 04/24/2007 | US7208163 Method for producing temperature-sensitive morbillivirus |
| 04/24/2007 | US7208162 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | US7208148 Chemically modified cytokines |
| 04/24/2007 | US7208141 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections |
| 04/24/2007 | CA2378671C 6-o-carbamate ketolide derivatives |
| 04/24/2007 | CA2332931C The treatment of renal colic with gaba analogs |
| 04/24/2007 | CA2243708C Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 04/24/2007 | CA2184345C Coordinate in vivo gene expression |
| 04/24/2007 | CA2144312C Unsaturated aliphatic dicarboxylic acids |
| 04/24/2007 | CA2141951C Inhibition of retrovirus infection |
| 04/24/2007 | CA2114849C Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/19/2007 | WO2007044933A1 Hepatitis c virus inhibitors |
| 04/19/2007 | WO2007044695A2 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 04/19/2007 | WO2007043715A1 Rna-binding peptide |
| 04/19/2007 | WO2007043640A1 Substance for use in treatment or prevention of hcv infection |
| 04/19/2007 | WO2007043542A1 Antituberculous composition comprising oxazole compounds |
| 04/19/2007 | WO2007043094A2 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof |
| 04/19/2007 | WO2007042884A1 Vaccines and methods to treat canine influenza |
| 04/19/2007 | WO2007042883A1 Inhibitors of the hiv integrase enzyme |
| 04/19/2007 | WO2007042786A2 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 04/19/2007 | WO2007042782A1 Chemical compounds |
| 04/19/2007 | WO2007042775A2 Conjugates of photosensitisers and antibodies |
| 04/19/2007 | WO2007042682A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 04/19/2007 | WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 04/19/2007 | WO2007041861A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 04/19/2007 | WO2007017758A3 Novel cysteine protease inhibitors and their therapeutic applications |
| 04/19/2007 | WO2007016153A3 Tilmicosin formulation |
| 04/19/2007 | WO2007008904A3 Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections |
| 04/19/2007 | WO2007003389A3 Substituted sulfolanyl pyrazoles and the use thereof |
| 04/19/2007 | WO2006136460A8 New adjuvant |
| 04/19/2007 | WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors |
| 04/19/2007 | WO2006128159A3 North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
| 04/19/2007 | WO2006115413A3 Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 04/19/2007 | WO2006091455A3 Molecular scaffolds for hiv-1 immunogens |
| 04/19/2007 | WO2006084210A3 Hif modulating compounds and methods of use thereof |
| 04/19/2007 | WO2006083553A3 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088084 Malic acid addition salts of terbinafine |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088009 Triterpene quaternary salts as biologically active surfactants |
| 04/19/2007 | US20070087407 Hepatitis C receptor protein CD81 |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087015 Multivalent dengue virus vaccine |
| 04/19/2007 | US20070086993 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 04/19/2007 | DE10238257B4 Sorbicillacton A und Sorbicillacton-A-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel Sorbicillactone A and sorbicillactone A derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 04/19/2007 | DE102005063375A1 Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen Antimicrobial preparations containing octenidine encapsulated in liposomes |
| 04/19/2007 | CA2625804A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 04/19/2007 | CA2624566A1 Chemical compounds |
| 04/19/2007 | CA2624497A1 Antituberculosis drug combination comprising oxazole compounds |
| 04/19/2007 | CA2624333A1 Compounds and methods for inhibiting hepatitis c viral replication |
| 04/19/2007 | CA2623932A1 Prevention of dental plaque and dental calculus in animals |
| 04/19/2007 | CA2623506A1 Inhibitors of the hiv integrase enzyme |
| 04/19/2007 | CA2621320A1 Vaccines and methods to treat canine influenza |
| 04/19/2007 | CA2588833A1 Compositions having a high antiviral and antibacterial efficacy |
| 04/18/2007 | EP1774977A2 Genetically engineered bleb vaccine |
| 04/18/2007 | EP1774975A1 Use of human lysozyme in preparation of medicine for treating acne |
| 04/18/2007 | EP1773867A2 Proteinaceous compounds and uses therefor |
| 04/18/2007 | EP1773847A2 Antibacterial agents |
| 04/18/2007 | EP1773826A2 C-met modulators and method of use |
| 04/18/2007 | EP1773819A1 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis |
| 04/18/2007 | EP1773816A2 Modulators of atp-binding cassette transporters |
| 04/18/2007 | EP1773790A1 Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors |
| 04/18/2007 | EP1773763A1 Lysine based compounds |
| 04/18/2007 | EP1773363A1 Ngna compositions and methods of use |
| 04/18/2007 | EP1773361A1 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality |
| 04/18/2007 | EP1773346A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 04/18/2007 | EP1773343A1 Antibacterial agents |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1773331A1 Imidazole and thiazole derivatives as antiviral agents |
| 04/18/2007 | EP1589995B1 Use of avian antibodies |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1450823B1 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones |
| 04/18/2007 | EP1441761B1 Methods of preventing and treating flavivirus infection in animals |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1419174B1 Process for preparing glycopeptide derivatives |
| 04/18/2007 | EP1411977B1 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases |
| 04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1343525B1 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE |
| 04/18/2007 | EP1307746B1 Identification of viral agents in breast ducts and antiviral therapy therefore |
| 04/18/2007 | EP1248645B1 Novel chimeric proteins and their use |
| 04/18/2007 | EP1206549B1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 04/18/2007 | EP1204420B1 Trehalose producing prokaryotic cells as vaccines |
| 04/18/2007 | EP1140166B1 Adjuvant containing N-formyl methionyl peptides for vaccines |
| 04/18/2007 | EP1137408B1 Agent for lowering endothelin levels |
| 04/18/2007 | EP1024835B1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |